Acute pancreatitis with hypertriglyceridaemia and early organ dysfunction
A 38-year-old man presents 36 hours after the onset of severe epigastric pain radiating to the back, with vomiting and distension. He drinks about 35 units of alcohol weekly and has a BMI of 33 kg/m²; he takes no regular medication. He is anxious and oliguric. Observations: pulse 118/min, blood pressure 104/64 mmHg, respiratory rate 26/min, SpO2 93% on air, temperature 38.1°C. Abdomen is distended and tender without guarding. Bloods: lipase 1,850 U/L (upper limit 60), alanine transaminase 42 U/L, bilirubin 14 µmol/L, calcium 1.82 mmol/L, glucose 15.8 mmol/L, lactate 3.4 mmol/L, creatinine 168 µmol/L (baseline 80), triglycerides 26 mmol/L, CRP 310 mg/L. Arterial blood gas on air: PaO2 8.9 kPa, PaCO2 3.8 kPa, pH 7.32. Ultrasound shows no gallstones and a normal common bile duct. He has received 2 L of crystalloid and morphine.
1. Using the modified Atlanta classification, how would you classify the severity at this point, and which variables drive your assessment? What information is still missing?
Read the worked answer
At 36 hours I would classify him as moderately severe pancreatitis with transient organ failure, pending reassessment. Modified Atlanta requires organ failure lasting more than 48 hours for severe disease, and we do not yet have that duration.
The drivers are:
- Renal: creatinine 168 µmol/L against a baseline of 80, with oliguria, meets acute kidney injury criteria.
- Cardiovascular: pulse 118/min and blood pressure 104/64 mmHg; not yet shock, but he is tachycardic and has received 2 L of fluid.
- Respiratory: PaO2 8.9 kPa on air gives a PaO2/FiO2 ratio of about 42 kPa (318 mmHg), so he does not meet ARDS criteria, but tachypnoea and SpO2 93% are concerning.
- Metabolic: lactate 3.4 mmol/L, hypocalcaemia 1.82 mmol/L, glucose 15.8 mmol/L and CRP 310 mg/L all predict a severe course.
- Aetiology: triglycerides 26 mmol/L are sufficient to cause pancreatitis, and alcohol may contribute. Gallstones are excluded on ultrasound.
Missing information includes urine output over time, fluid balance, BUN, haematocrit, chest imaging for effusion, and a pancreas-protocol CT if he deteriorates. The key missing variable is persistence of organ failure beyond 48 hours.
2. Outline your management in the first 24 hours, including fluid strategy, nutrition, antibiotics and specific treatment of his hypertriglyceridaemia. What would you avoid?
Read the worked answer
Fluids: give moderate goal-directed crystalloid, approximately 5–10 mL/kg/h, and reassess every 4–6 hours using urine output, heart rate, lactate, haematocrit and creatinine. Avoid both under-resuscitation and the older practice of very aggressive fluid loading, which increases respiratory failure and abdominal compartment pressure.
Supportive care: oxygen to keep SpO2 above 94%, analgesia, antiemetics, nasogastric tube if vomiting, correction of potassium and magnesium, and monitoring of calcium and glucose. Insert a urinary catheter to measure output.
Nutrition: start enteral nutrition within 24–48 hours once vomiting is controlled. Nasogastric feeding is acceptable if nasojejunal access is difficult. Parenteral nutrition is reserved for failure of enteral feeding.
Antibiotics: do not prescribe prophylactically. Use them only for proven or strongly suspected infected necrosis or another infection.
Hypertriglyceridaemia: treat with an insulin infusion even if glucose is only moderately raised, aiming to suppress lipolysis. Consider plasma exchange if triglycerides remain above about 20 mmol/L with organ failure or if insulin fails. Stop alcohol and review long-term fibrates and diet.
Avoid: urgent ERCP, since there is no cholangitis or duct stone; immediate pancreatic CT in a stable patient; and early surgical necrosectomy.
3. On day 4 he develops fever of 39°C, white cell count 22 × 10⁹/L and worsening respiratory function. What is your diagnostic and interventional strategy, and why not operate immediately?
Read the worked answer
I would look for infected necrosis or an infected peripancreatic collection, but also for ventilator-associated pneumonia, line infection and abdominal compartment syndrome. I would take blood cultures, send relevant cultures, and perform a contrast-enhanced pancreas-protocol CT to define the extent of necrosis and identify gas or a drainable collection.
If a collection is present, the strategy is a step-up approach: intravenous antibiotics with anaerobic cover, then percutaneous or endoscopic drainage of the collection, with culture of the fluid. A surgical necrosectomy is considered only if drainage fails or if there is ongoing sepsis with no drainable collection.
I would not operate immediately because early open necrosectomy in acute pancreatitis carries very high mortality. Necrotic tissue is poorly demarcated in the first two weeks, and surgery creates further inflammatory injury. Delaying intervention for 3–4 weeks allows the collection to become walled off and permits a minimally invasive approach. The exception is an acute abdomen with perforation or uncontrolled haemorrhage, which is not described here. Meanwhile, continue organ support, enteral nutrition and close monitoring.